About this trial
The goal of this observational study is to evaluate the possibility to use prenatal ultrasonography for diagnosis and prognostic guidance in cases of suspected fetal thyroid changes in fetuses belonging to women with thyroid disease and women with low obstetric risk (i.e., pregnancy not complicated by maternal and/or fetal pathology) between 14 and 37 gestational weeks.
The main question it aims to answer is:
Is it possible to diagnose thyroid disease in fetuses early using measurable parameters of the fetal thyroid through ultrasonography?
Eligibility criteria
Qualifiers
Participants between 14 and 37 gestational weeks, who will be followed for the entire period of pregnancy, up to delivery, at the same enrolling center
Obtaining informed consent for participation in the study
Maternal age between 18 and 45 years (extremes included)
Participants with good understanding of the Italian language
Disqualifiers
Smoking participants
Patients with BMI>30
Absence of correct dating of pregnancy within the first trimester
Pathological conditions (e.g., malabsorptive or socioeconomic conditions that may interfere with fetal growth)
Trial design
Treatments tested in this trial
- Description of the trend of major thyroid ultrasound biometric parameters